Considerable on MSN
Oral GLP-1 obesity drugs near wider access
The post Oral GLP-1 Obesity Drugs Near Wider Access appeared first on Considerable.
Travere Therapeutics, Inc. today announced that, based on preliminary and unaudited financial data, the Company expects total U.S. net product sales for the fourth quarter of 2025 to be approximately ...
WAKIX 2025 Preliminary Net Revenue of ~$868 Million; 2026 WAKIX Net Revenue Guidance of $1.0 – $1.04 Billion on Track for Blockbuster Status in NarcolepsyOn Track to Extend the Pitolisant Franchise ...
This form of rapid-acting inhaled insulin, recently introduced in India by the name Afrezza, is said to offer an important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback